Live Breaking News & Updates on Agile therapeutics daily

Stay informed with the latest breaking news from Agile therapeutics daily on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Agile therapeutics daily and stay connected to the pulse of your community

Agile Therapeutics (NASDAQ:AGRX) Receives "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a research note released on Wednesday morning, Stock Target Advisor reports. The firm currently has a $12.00 target price on the specialty pharmaceutical company’s stock. HC Wainwright also issued estimates for Agile Therapeutics’ Q2 2023 earnings at ($3.45) EPS, […]

United-states , Agile-therapeutics-inc , Virtu-financial , Blackrock-inc , Agile-therapeutics-company-profile , Renaissance-technologies , Agile-therapeutics , Get-rating , Stock-target-advisor , Therapeutics-stock-down , Street-group

Agile Therapeutics, Inc. (NASDAQ:AGRX) Expected to Earn FY2023 Earnings of ($6.05) Per Share

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) – Stock analysts at HC Wainwright issued their FY2023 earnings per share estimates for Agile Therapeutics in a research report issued to clients and investors on Wednesday, June 7th. HC Wainwright analyst O. Livnat anticipates that the specialty pharmaceutical company will post earnings per share of ($6.05) for […]

United-states , Blackrock-inc , Renaissance-technologies , Agile-therapeutics-company-profile , Nasdaq , Virtu-financial , Agile-therapeutics-inc , Agile-therapeutics , Get-rating , Agile-therapeutic , Therapeutics-trading-down

Agile Therapeutics (NASDAQ:AGRX) Cut to Sell at StockNews.com

StockNews.com lowered shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) from a hold rating to a sell rating in a research note published on Thursday. Agile Therapeutics Price Performance AGRX stock opened at $6.45 on Thursday. The firm has a fifty day moving average price of $2.15 and a two-hundred day moving average price of […]

Renaissance-technologies , Virtu-financial , Blackrock-inc , Agile-therapeutics-inc , Agile-therapeutics , Get-rating , Street-group , Chien-te-yen , Agile-therapeutics-daily , Nasdaq-agrx , Agrx

Agile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest Update

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 33,800 shares, an increase of 350.7% from the March 31st total of 7,500 shares. Currently, 3.8% of the company’s stock are short sold. Based […]

Blackrock-inc , Virtu-financial , Nasdaq , Renaissance-technologies , Agile-therapeutics-inc , Agile-therapeutics , Get-rating , Street-group , Chien-te-yen , Agile-therapeutics-daily , Nasdaq-agrx

Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a report published on Wednesday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Stock Performance Shares of NASDAQ AGRX opened at $6.98 on Wednesday. Agile Therapeutics has a fifty-two week low of $6.42 and a fifty-two […]

Blackrock-inc , Agile-therapeutics-inc , Renaissance-technologies , Virtu-financial , Agile-therapeutics , Get-rating , Street-group , Chien-te-yen , Agile-therapeutics-daily , Nasdaq-agrx , Agrx

Short Interest in Agile Therapeutics, Inc. (NASDAQ:AGRX) Declines By 96.7%

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) was the target of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 7,500 shares, a decline of 96.7% from the March 15th total of 225,700 shares. Based on an average daily volume of 17,000 shares, the […]

Renaissance-technologies , Virtu-financial , Agile-therapeutics-company-profile , Blackrock-inc , Agile-therapeutics-inc , Nasdaq , Agile-therapeutics , Get-rating , Jane-street-group , Chien-te-yen , Agile-therapeutics-daily

StockNews.com Begins Coverage on Agile Therapeutics (NASDAQ:AGRX)

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a report issued on Tuesday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Stock Performance Shares of NASDAQ AGRX opened at $0.23 on Tuesday. Agile Therapeutics has a fifty-two week low of $0.18 and a […]

Virtu-financial , Agile-therapeutics-inc , Renaissance-technologies , Blackrock-inc , Agile-therapeutics , Get-rating , Street-group , Chien-te-yen , Agile-therapeutics-daily , Nasdaq-agrx , Agrx

Agile Therapeutics (NASDAQ:AGRX) Now Covered by StockNews.com

StockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a research report report published on Monday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Price Performance NASDAQ AGRX opened at $0.23 on Monday. The company has a market capitalization of $10.79 million, a PE ratio […]

Renaissance-technologies , Agile-therapeutics-inc , Blackrock-inc , Virtu-financial , Agile-therapeutics , Get-rating , Street-group , Chien-te-yen , Agile-therapeutics-daily , Nasdaq-agrx , Agrx

Agile Therapeutics (NASDAQ:AGRX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a note issued to investors on Monday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Price Performance AGRX stock opened at $0.22 on Monday. The company has a market cap of $10.29 million, a P/E ratio […]

Agile-therapeutics-inc , Agile-therapeutics-company-profile , Renaissance-technologies , Virtu-financial , Blackrock-inc , Agile-therapeutics , Get-rating , Street-group , Chien-te-yen , Agile-therapeutics-daily , Nasdaq-agrx

Agile Therapeutics (NASDAQ:AGRX) Share Price Passes Above 50-Day Moving Average of $0.22

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.22 and traded as high as $0.30. Agile Therapeutics shares last traded at $0.29, with a volume of 576,188 shares. Wall Street Analyst Weigh In Separately, StockNews.com initiated […]

United-states , Agile-therapeutics-inc , Blackrock-inc , Renaissance-technologies , Nasdaq , Agile-therapeutics , Get-rating , Street-group , Agile-therapeutics-daily , Nasdaq-agrx , Agrx